Abstract:Eight new flavonoids, including two β-hydroxy/methoxychalcones, velutones A and B (1 and 2), two 1,3-diarylpropan-1-ols, velutols C and D (3 and 4), a dihydroxychalcone, velutone E (5), a chalcone, velutone F (6), a furanoflavanone, velutone G (7), and a furanoflavonol, velutone H (8), and 14 known compounds were isolated from Millettia velutina. Their structures were determined by high-resolution electrospray ionisation mass spectrometry (HR-ESIMS) and spectroscopic data analyses and time-dependent density functional theory electronic circular dichroism (TD-DFT–ECD) calculations. Among the isolated constituents, compound 6 exhibited the most potent inhibitory effect (IC50: 1.3 μM) against nigericin-induced IL-1β release in THP-1 cells. The initial mechanism of action study revealed that compound 6 suppressed NLRP3 inflammasome activation via blocking ASC oligomerization without affecting the priming step, which subsequently inhibited caspase-1 activation and IL-1β secretion. Most importantly, compound 6 exerted potent protective effects in the LPS-induced septic shock mice model by improving the survival rate of mice and suppressing serum IL-1β release. These results demonstrated that compound 6 had the potential to be developed as a broad-spectrum NLRP3 inflammasome inhibitor for the treatment of NLRP3-related disease.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jnatprod.0c00478?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jnatprod.0c00478</a>.Figures of 1H and 13C NMR, HSQC, HMBC, 1H–1H COSY, NOESY, and HR-ESIMS spectra, most stable conformers, Western blot analysis, and approval of the study by the Ethics Committee on Animal Experimentation, discussions of general experimental procedures, plant material, extraction and isolation, computational details, cell culture and stimulation, ELISA, Western blot, lactate dehydrogenase assay, ASC speck staining detection, LPS-induced septic shock model, and statistical analysis, and tables of energy analysis, (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00478/suppl_file/np0c00478_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

The Bioactive Limonoids from Toona Ciliate As NLRP3 Inflammasome Inhibitors

Toonaolides A–X, limonoids from Toona ciliata: Isolation, structural elucidation, and bioactivity against NLRP3 inflammasome

Cytotoxic Limonoids From The Twigs And Leaves Of Toona Ciliata

Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis

Anti-inflammatory Effect of a Limonin Derivative In Vivo and Its Mechanisms in RAW264.7 Cells

Novel Isoalantolactone-Based Derivatives as Potent NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization

Euterpe oleracea Mart. Bioactive Molecules: Promising Agents to Modulate the NLRP3 Inflammasome

Chloranthalactone B covalently binds to the NACHT domain of NLRP3 to attenuate NLRP3-driven inflammation

Discovery, Total Synthesis, and Anti‐inflammatory Evaluation of Naturally Occurring Naphthopyrone‐Macrolide Hybrids as Potent NLRP3 Inflammasome Inhibitors

Identification of Phenolic Compounds from a Unique Citrus Species, Finger Lime (citrus Australasica) and Their Inhibition of LPS-induced NO-releasing in BV-2 Cell Line

Design, synthesis and biological evaluation of tanshinone IIA derivatives as NLRP3 inflammasome inhibitors

Constituents from Dolichos lablab L. Flowers and Their Anti-Inflammatory Effects via Inhibition of IL-1β Release

New anti-inflammatory limonoids from the fruits of Melia azedarach

Flavonoids with Inhibitory Effects on NLRP3 Inflammasome Activation from Millettia velutina

Saponins as potential novel NLRP3 inflammasome inhibitors for inflammatory disorders

Discovery of 4-((E)-3,5-dimethoxy-2-((E)-2-nitrovinyl)styryl)aniline derivatives as potent and orally active NLRP3 inflammasome inhibitors for colitis

Discovery of alantolactone as a natural NLRP3 inhibitor to alleviate NLRP3‐driven inflammatory diseases in mice

Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis

Inhibitory Effect of Cayratia Albifolia C. L. Li Extract on LPS-induced Inflammation of RAW264.7 Cells by Regulating the Nrf2/HO-1 Axis

Novel Isoquinoline Alkaloid Litcubanine A - A Potential Anti-Inflammatory Candidate

Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1